publications

As we advance our mission to develop breakthrough therapies with the goal of fundamentally changing the way we treat, prevent, and control progressive and infectious respiratory diseases, we regularly share the progress of our research.

To learn more about our science and research findings, download the PDFs below which are organized by iSPERSE and iCALM:

iSPERSE

RDD 2012 — Development of an iSPERSE™ Based Platform for the Delivery of Macromolecules via Dry Powder Formulations / PDF

RDD 2012 — Formulation Characterization of a Novel Levofloxacin Pulmonary Dry Powder Drug Delivery Technology / PDF

ATS 2012 — A Novel Inhaled Dry Powder Delivery Platform for the Delivery of Large Molecule Drugs to the Lung for Local and Systemic Treatments / PDF

ATS 2011 — Efficacy of Fluticasone and Salmeterol in a Novel Inhaled Dry Powder Delivery Platform / PDF

ISAM 2011 Conference abstract — Deposition of Aerosolized Liquid Formulation in Ferrets by 3D CT / Spect Imaging / PDF

ISAM 2011 Conference abstract — A Novel Inhaled Dry Powder Delivery Platform; Efficacy of Fluticasone and Salmeterol During Allergic Asthm / PDF

iCALM

ERS 2012 — Inhaled Calcium Salts Reduce Expression of Inflammatory Mediators Associated with Tobacco Smoke Exposure to Reduce Airway Inflammation / PDF

ERS 2012 — Inhaled Cationic Salts Modulate Macrophage Function to Reduce Inflammation During LPS Induced Lung Injury / PDF

ATS 2012 — Inhaled Cationic Airway Lining Modulator (iCALM) attenuates allergen-induced eosinophilic bronchitis / PDF

ATS 2012 — Cationic salt dry powders inhibit inflammatory responses in a rhinovirus-induced exacerbation mouse model of allergic airway inflammation

ATS 2012 — Extracellular Calcium During Bacterial Challenge Augments the Innate Immune Response of Monocyte Derived Macrophages / PDF

ATS 2012 — Inhaled Calcium Based Dry Powder Enhances Whole Lung Mucociliary Clearance In Sheep / PDF

ATS 2012 — Reduced neutrophilic inflammation by inhalation of dry powder calcium salts in a mouse model of sub-chronic tobacco smoke exposure / PDF

ATS 2011 — Inhaled Calcium Salts Reduce Acute Airway Inflammation Associated with Tobacco Smoke Exposure / PDF

ATS 2011 — Inhaled Cationic Salts Inhibit Infection of Multiple Viral Pathogens and Prevent Influenza Infection in Vivo / PDF